● Заявки по безработице в США упали сильнее прогноза
● Apple вложит $1 млрд в создание новых рабочих мест в США, заявил глава компании Тим Кук в интервью CNBC. Компания планирует создать инвестиционный фонд для развития высокотехнологичного производства на территории Штатов.
● Tesla увеличила чистый убыток на 40%.Убыток Tesla в I квартале увеличился до $330 млн, несмотря на рост выручки более чем в два раза. Гендиректор Tesla Илон Маск выразил уверенность в том, что компания начнет производство электромобилей Model 3 в июле. Также он сказал, что однажды Tesla, возможно, обгонит по рыночной капитализации Apple
● Выручка Facebook в I квартале 2017 г. в годовом выражении выросла на 49% до $8,03 млрд, превзойдя ожидания аналитиков, прогнозировавших в среднем выручку в $7,83 млрд.
Чистая прибыль соцсети Facebook по итогам I квартала 2017 г. выросла на 76% и составила $3,064 млрд против $1,738 млрд годом ранее. Скорректированная прибыль на акцию составила $1,04 по сравнению с 60 центами в аналогичный период прошлого года.
● Миллион машин GM пылятся на складах.На автомобильном рынке США сложилась тревожная ситуация. Продажи падают четвертый месяц подряд, при этом количество автомобилей на складах увеличилось до уровня кризисного 2009 г.
● Число буровых вышек в США за год выросло вдвое
● Результаты Siemens в I квартале улучшились и превзошли прогнозы аналитиков
Gapping down
In reaction to disappointing earnings/guidance:
- SRC -12.7%, ENTL -11.3%, FTK -11%, COMM -10.3%, CAKE -7.6%, GKOS -6.6%, RUBI -6.3%, AVP -5.8%, MITL -5.4%, BEAT -5.1%, ANDE -5%,
- CBL -4.4%, OUT -4%, RICE -4%, BCRX -4%, CTL -3.9%, CERS -3.8%, NUS -3.8%, LB -3.4%, EYES -3.1%, FMSA -3.1%, LPI -2.9%, PXD -2.8%,
- IAC -2.8%, GOGO -2.8%, GSAT -2.8%, DDD -2.4%, LVLT -2.4%, MD -2.2%, AGIO -2.1%, TSLA -1.9%, RIG -1.9%, AUY -1.9%, CRIS -1.9%,
- CAR -1.8%, PBF -1.7%, RYN -1.6%, DNKN -1.5%, MUR -1.3%,WMGI -1.2%, GTE -1.2%, ZUMZ -1.1%, MUX -1.1%, SSRI -1%, CNQ -1%,
- HII -1%, RFP -1%, FB -0.9%, ACHN -0.9%, QRVO -0.8%, TCAP -0.8%, OXY -0.8%, KHC -0.7%
Select metals/mining stocks trading lower:
- VALE -1.7%, HMY -1.4%, AKS -1.2%, ABX -1.1%, NEM -1%, SLW -1%, X -0.9%, CLF -0.8%
Select oil/gas related names showing early weakness:
- MRO -1.5%, SDRL -1.9%, HES -1.8%, WLL -1.8%, CHK -1.1%, PBR -1.1%, NE -0.9%, OAS -0.9%, HAL -0.8%
Other news:
- BPMX -30.6% (phase 2b clinical trial evaluating BPX-01)
- WINT -22.1% (to delist from the NASDAQ, will suspend trading in the Company’s shares at the open of business on Friday, May 5, 2017)
- PETX -12.9% (prices registered direct offering of 5 mln shares at $5.25/share)
- LNTH -8.9% ( commences 3 mln common stock offering by its existing stockholders )
- GDDY -3.8% (announces public offering of 24,000,000 shares of Class A common stock; expects to repurchase, from the selling stockholders, an aggregate of $275 million of limited liability company units of Desert Newco)
- CVNA -2.6% (continued weakness)
- AMAG -1.5% (commences $250 mln offering of Convertible Senior Notes due 2022 )
- HNR -1.4% (Harvest Natural confirms payment of of $5.75 per share dividend to be completed May 4, termination of trading, and time of dissolution)
- MCRN -1.1% (prices 12 mln share common stock offering by certain selling stockholders at $17.20 per share)
- HUBS -1% ( to offer $300 mln aggregate principal amount of Convertible Senior Notes due 2022, in a private offering)
Analyst comments:
- FIZZ -5.8% (initiated with a Sell at Maxim Group; tgt $33)
- GRMN -1.5% (downgraded to Underweight from Neutral at JP Morgan)
- TSCO -1% (downgraded to Perform from Outperform at Oppenheimer)
Gapping up
In reaction to strong earnings/guidance:
- KPTI +29.6%, SITO +17.3%, TLRD +14.2%, SFS +11.6%, FIVN +11.1%, HIIQ +10.8%, HIVE +10.2%, ATSG +9.5%, TGB +8.9%, BCOR +8.5%,
- DATA +8.4%, FORM +8.4%, WTI +8.4%, AIRG +8.2%, AOSL +8%, FIT +7.4%, XPO +6.6%, PCOM +6.4%, ARWR +5.8%, RAIL +5.6%, GNCA +5.6%,
- TVIA +5.4%, EBIO +5.4%, PIP +5%, SQ +5%, LGCY +4.9%, GTN +4.8%, GMED +4.7%, EMKR +4.7%, NVDQ +4.6%, HDSN +4.4%, BRKR +3.4%,
- HSBC +3.4%, HK +3%, OSUR +3%, HMHC +3%,VVUS +2.9%, ARRS +2.8%, SRI +2.6%, EXTR +2.4%, MFC +2.3%, EZPW +2.3%, MTDR +2.2%,
- ALB +2.2%, HZN +2.1%, LHCG +2.1%, ICPT +2.1%, OMF +2%, CLVS +1.9%, COT +1.8%, GPN +1.8%, GLUU +1.6%, INCY +1.6%, WPX +1.5%,
- CLR +1.4%, RDS.A +1.4%, TWO +1.3%, IO +1.2%, AGI +1.2%, PRU +1.1%, AIG +1.1%, STMP +1.1%, JCAP +1%, .
Other news:
- APHB +20.8% (still checking; light volume)
- SCON +14.6% (10% owner Director Kopp disclosed the purchase of 200K shares )
- MNKD +12% (Mannkind and One Drop enter into a collaborative agreement)
- CLSN +8.2% (announces updated date from its Phase Ib dose escalating clinical trial combining GEN-1 with the standard of care)
- RXDX +6.5% (prices 12.5 million share common stock offering at $6.15/share; gross proceeds expected to be $76.9 mln)
- KPTI +5.4% (Karyopharm Therapeutics and Anivive Lifesciences sign exclusive global license agreement for verdinexor; KPTI to receive $1 mln upfront payment and eligible to receive up to $43.5 mln in future milestones, plus royalties )
- SGMO +5.4% (granted orphan designation by the FDA for its compound for the treatment of hemophilia A)
- CTRV +5% (announces it is developing a second-generation formulation of TXL)
Analyst comments:
- FSLR +2.5% (upgraded to Buy from Neutral at BofA/Merrill )
- EMES +0.8% (upgraded to Buy from Hold at Stifel )
- JWN +0.8% (upgraded to Overweight from Neutral at Atlantic Equities)
Блог трейдера